I recently visited the NeoTract offices in Pleasanton, CA with some of my colleagues from across the country for advanced training to treat benign prostatic hyperplasia with the remarkable Urolift System. We not only shared best practices but I got to try my hand at assembling a Urolift device. I can attest firsthand that it is a truly an intricate and well-engineered device!
What is BPH?
If you suffer with symptoms associated with an enlarged prostate, otherwise known as BPH, you are not alone. This common condition affects nearly 40 million men in the United States and I see many patients for BPH each month.
Some of the common symptoms include:
- Frequent urination, during the day and/or at night
- A slow or weak urine stream
- Dripping or dribbling of urine after urinating
- Incomplete bladder emptying
- Sudden and urgent need to urinate
- Painful straining to urinate
- Bladder infections
While many men are often given medication to treat their BPH symptoms, they typically only work in 50% of patients. Effects are usually temporary, because the prostate continues to grow. Of great concern is a recently recognized side effect of dementia from these medications, as well as previously recognized problems like dizziness, low blood pressure and ejaculation and erectile dysfunction. As most of my patients are aware, I specialize in minimally invasive urological procedures. Last year I introduced Urolift in my practice because of its superb clinical outcomes in the 5 years since its introduction in the US. After doing many Urolift procedures, and being one of the most experienced practitioners in the Western US, I can tell you that it has forever changed the landscape of minimally invasive BPH therapies. It is far more effective than most other procedures and the results are typically long lasting.
The Urolift System is an effective, non-surgical alternative treatment for BPH, not just manage the symptoms! Learn if you are candidate for Urolift – call 888-735-4336.
Learn more about Neotract and Urolift System
NeoTract, a wholly owned subsidiary of Teleflex Incorporated, focused on addressing unmet needs in the field of urology, presented new clinical data from numerous studies of the UroLift® System for patients with benign prostatic hyperplasia (BPH) at the 36th World Congress of Endourology (WCE) 2018 Annual Conference held on September 20-23 in Paris.
Comments are closed.